ABSTRACT
Continuous growth in fluoroarene production has led to environmental pollution and health concerns owing to their persistence, which is attributed to the stable C-F bond in their structures. Herein, we investigated fluoroarene decomposition via hydrodefluorination using a rhodium-based catalyst, focusing on the effects of the chemical structure and functional group on the defluorination yield. Most compounds, except (pentafluoroethyl)benzene, exhibited full or partial reduction with pseudo-first-order rate constants in the range of 0.002-0.396 min-1 and defluorination yields of 0%-100%. Fluoroarenes with hydroxyl, methyl, and carboxylate groups were selected to elucidate how hydrocarbon and oxygen-containing functional groups influence the reaction rate and defluorination. Inhibition of the reaction rate and defluorination yield based on functional groups increased in the order of hydroxyl < methyl < carboxylate, which was identical to the order of the electron-withdrawing effect. Fluoroarenes with polyfluoro groups were also assessed; polyfluoro groups demonstrated a different influence on catalyst activity than non-fluorine functional groups because of fluorine atoms in the substituents undergoing defluorination. The reaction kinetics of (difluoromethyl)fluorobenzenes and their intermediates suggested that hydrogenation and defluorination occurred during degradation. Finally, the effects of the type and position of functional groups on the reaction rate and defluorination yield were investigated via multivariable linear regression analysis. Notably, the electron-withdrawing nature of functional groups appeared to have a greater impact on the defluorination yield of fluoroarenes than the calculated C-F bond dissociation energy.
ABSTRACT
Recently, an increasing number of pharmaceutical compounds has become fluorinated. Owing to their pharmacological efficacy, the use of these fluorinated pharmaceuticals continues to grow, and they constitute 20% of the drugs on the current market. However, only a few studies have investigated the fate and transformation of these emerging contaminants in natural and engineered aquatic environments. In the present study, the H2-based reductive transformation of three fluorinated pharmaceutical compounds (levofloxacin, sitagliptin, and fluoxetine) were investigated using alumina-supported monometallic and bimetallic catalysts of the Pt-group noble metals (i.e., Ru, Rh, Pd, and Pt) under ambient temperature and pressure conditions. Degradation of all three compounds was observed with catalytic reactivity ranging from 4.0 × 10-3 to 2.14 × 102 L/(min·gcat), in which fluoxetine generally showed the highest reactivity, followed by sitagliptin and levofloxacin. The fluorination yields and transformation products were characterized for each fluorinated compound and three different degradation mechanisms were elucidated: 1) hydrodefluorination of C-F bond to CH bond, 2) hydrogenation of aromatic ring, and 3) reductive cleavage of CO bond from phenyl ether. Toxicity assessment using Aliivibrio fischeri showed there were no significant changes in toxicity over levofloxacin and sitagliptin degradation, suggesting the formation of no highly toxic by-products during catalytic reduction. For fluoxetine, an increased toxicity was observed during its degradation while ECOSAR-predicted toxicity values of all identified intermediates were lower than that of fluoxetine, suggesting the formation of unidentified secondary by-products that contribute to the overall toxicity. The study showed that catalytic reduction is a promising remediation process for treating and defluorinating the fluorinated pharmaceutical compounds.
